Virtual Exhibition Hall

At Olympus we aim to deliver total medical solution with complete customer satisfaction. Our medical products cover gastrointestinal endoscopes, endotherapy devices, endoscopic ultrasound systems, surgical endoscopes and instruments and integrated operating theatre. As a leading endoscope company, Olympus is promoting the advancement of minimally invasive diagnosis and treatment as well as product development to offer our customers improved safety, security, quality and productivity.

B. Braun is one of the world’s leading providers and manufacturers of healthcare solution today. For more than 180 years, we develop innovative and effective solutions to protect and improve the health of people around the world.

The Hospital Care Division of B. Braun offers a complete product portfolio in Total Parenteral Nutrition, Plasma Volume Replacement, Central Venous Catheters as well as a selected range of Added Value Generics, mainly IV Anesthetics & convenience Antibiotics. Our products have long been used in well-established markets.

The Aesculap division has been synonymous with competence in the operating room for over 150 years. The division is a partner for surgical and interventional treatment concepts in inpatient and outpatient care. Aesculap focuses on the following therapeutic areas: abdominal surgery, cardiothoracic surgery, orthopaedic surgery, spine surgery, neurosurgery, interventional vascular therapy and sterile goods management.​​​​​​​​​​​​​​

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. In the field of biosimilar, we focus on autoimmune disease and oncolgoy. In 2019, The first biosimliar product by Fresenius kabi was launched. Within transfusion medicine and ceth therapies, Fresenius kabi offers products for collection of blood components and extracorporeal therapies.

Beginning in 1934 as Japan’s pioneering photographic film maker, Fujifilm has leveraged its imaging and information technology to become a global presence known for innovation in healthcare, graphic arts, optical devices, highly functional materials and other high-tech areas.

At Fujifilm, we are continuously innovating — creating new technologies, products and services that inspire and excite people everywhere. Our goal is to empower the potential and expand the horizons of tomorrow’s businesses and lifestyles. We take an open and flexible attitude to innovation, combining our own original technology with human resources, expertise and technology from around the world. Through this powerful synergy, we rapidly and nimbly develop new solutions that address the true needs of our global customers.

We will use leading-edge, proprietary technologies to provide top-quality products and services that contribute to the advancement of culture, science, technology and industry, as well as improved health and environmental protection in society. Our overarching aim is to help enhance the quality of life of people worldwide.

Fueled by innovation at the intersection of biology and technology, we’re developing the next generation of smarter, less invasive, more personalized treatments.

From advanced mapping and navigation to robotic assisted solutions, we are delivering care in the hardest to reach parts within the human body. And by focusing highly engineered and intelligent treatments exactly where they’re needed, we’re protecting what’s healthy and delivering care to what’s not. We’re helping to restore sight in ways that feel more natural and imperceptible, so people feel more like themselves again.

Since its beginnings in 1945, the KARL STORZ family company has grown into a global manufacturer and distributor of endoscopes, medical instruments, and devices. We are no giant on an international scale but a leader in the things that matter: creativity, flexibility, and expertise.

Our range of endoscopic instruments for human medicine, veterinary medicine, and industrial endoscopy now includes more than 15,000 products. The most recent KARL STORZ developments are in digital documentation systems and comprehensive operating room concepts. As a system supplier, the company combines its expertise in endoscopy with software solutions to achieve integration in the operating room and to support clinical process and resource management.

Merck, a leading science and technology company, operates across life science, healthcare, and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

Based in Hong Kong, Pacific Medical Systems Ltd is a leading provider of innovative and quality surgical products in Asia since 2004. Initially focusing in cardiovascular surgery with products such as Medistim ultrasonic guidance and graft assessment systems, lightweight Xenosys loupes, headlights and surgical video documenting systems, CoroNeo and Rultract specialty retractors, Lifotronic, warmer unit with disposable blanket, LSI Cor-Knot devices, Medela digital chest drainage system, Praesidia sternal closure systems,; and recently complementing with our GE cardiovascular and MSK ultrasound systems with the bespoke Episurf patient customized knee and talus device implants for the orthopedic segment.

Please come and visit our booth

Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in over 150 countries with more than 21,000 employees worldwide.

Our special status as a laboratory governed by a foundation means each year, we can invest over 20% of our revenue from brand-name medicines in research and development, a strategy that helps us to discover new treatments more easily.

Day in, day out, we capitalize on the talent and engagement of the 21,400 people employed throughout our Group to make our brand-name and generic medicines available to patients in over 150 countries.

These medicines are the fruit of our knowledge and expertise in our therapeutic areas of oncology, neuroscience, immuno-inflammation, cardiovascular diseases, and metabolism.

Solar-med limited

We are an established medical device distributor with over 20 years of experience in the medical device market in Hong Kong. As an integral part of our distribution business, we also provide one-stop medical device solutions.

Teleflex Medical Asia Pte. Ltd.

We believe that the future of healthcare is in the people we empower. Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives.

Teleflex Surgery is working at the cutting edge of surgical innovation to deliver a comprehensive portfolio of products that addresses the challenges of an ever-evolving surgical environment.

Our extensive minimally invasive solutions portfolio includes innovative percutaneous laparoscopy and Weck branded fascial closure and ligation products, while our trusted portfolio of Pilling Surgical Instruments provides surgeons with a comprehensive range of time-tested tools for a variety of specialties.

Founded in 1921, the Otsuka Pharmaceutical Factory Inc. began producing intravenous solutions in 1946 and then Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) was established in 1964. Through its nutritional therapies provided in clinical care, it has secured a leadership position in this field. In 1971, Otsuka Pharmaceutical also began developing various pharmaceutical products. In addition, leveraging the expertise and experience gained from the pharmaceutical manufacturing process, Otsuka Pharmaceutical applied this knowledge to the development of nutraceutical products. Today, Otsuka Pharmaceutical's global leadership in pharmaceuticals, nutrition, and health care is widely recognized.

In 1997, Otsuka Pharmaceutical (Hong Kong) Limited (Otsuka Hong Kong) was officially established. As a subsidiary of Otsuka Pharmaceutical in Japan, Otsuka Hong Kong is primarily responsible for the marketing and sales of Otsuka Pharmaceutical Group products in Hong Kong and Macau.

With societal changes and economic development, the demand for healthcare products among Hong Kong residents is rapidly increasing. Several Otsuka Pharmaceutical products have successfully penetrated the health and pharmaceutical markets, making significant contributions to the health of the people in Hong Kong. Among these are some well-known products, such as Pocari Sweat, Oronine H Ointment, Aminoleban EN, Pletaal and Abilify.